Peter McErlean

2.0k citations

18 papers · 1.5k indexed · h-index 15

Impact in

Infectious Diseases top 2%
- Viral gastroenteritis research and epidemiology
- Parvovirus B19 Infection Studies
Epidemiology top 5%
- Respiratory viral infections research
- Influenza Virus Research Studies

Papers in ⓘ

Infectious Diseases 6
- Viral gastroenteritis research and epidemiology 6
Emergency Medical Services 2

Co-authors: Ian M Mackay (7 shared papers)Michael D. Nissen (7 shared papers)Katherine E. Arden (5 shared papers)Theo P. Sloots (6 shared papers)Stephen B. Lambert (4 shared papers)David J. Speicher (2 shared papers)T. P. Sloots (1 shared paper)Laura A. Shackelton (2 shared papers)
Journals: Journal of Clinical Virology (4 papers)American Journal of Respiratory and Critical Care Medicine (3 papers)Clinical & Experimental Immunology (2 papers)BMC Medical Genomics (1 paper)Science Immunology (1 paper)
Partner nations: United States Australia United Kingdom

In The Last Decade

Peter McErlean

18 papers receiving 1.4k citations

Peers

Countries citing papers authored by Peter McErlean

Since Specialization

Citations

This map shows the geographic impact of Peter McErlean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McErlean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McErlean more than expected).

Fields of papers citing papers by Peter McErlean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter McErlean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McErlean. The network helps show where Peter McErlean may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter McErlean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter McErlean Line = papers co-authored together Peter McErlean links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections Journal of Medical Virology ·Katherine E. Arden, Peter McErlean, Michael D. Nissen, Theo P. Sloots, Ian M Mackay	2006	305
2	Evidence of human coronavirus HKU1 and human bocavirus in Australian children Journal of Clinical Virology ·T. P. Sloots, Peter McErlean, David J. Speicher, Katherine E. Arden, Michael D. Nissen, Ian M Mackay	2005	284
3	Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis Journal of Clinical Virology ·Peter McErlean, Laura A. Shackelton, Stephen B. Lambert, Michael D. Nissen, Theo P. Sloots, Ian M Mackay	2007	142
4	Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections? Journal of Clinical Virology ·Ristan M. Greer, Peter McErlean, Katherine E. Arden, Cassandra E. Faux, Andreas Nitsche, Stephen B. Lambert, Michael D. Nissen, Theo P. Sloots, Ian M Mackay	2009	133
5	Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa Genome Medicine ·Peter McErlean, Sergejs Berdnikovs, Sílvio Favoreto, Junqing Shen, Assel Biyasheva, Rebecca Barbeau, Chris J. Eisley, Andrea J. Barczak, Theresa Ward, Robert P. Schleimer, David J. Erle, Homer A. Boushey, Pedro C. Avila	2014	111
6	Distinguishing Molecular Features and Clinical Characteristics of a Putative New Rhinovirus Species, Human Rhinovirus C (HRV C) PLoS ONE ·Peter McErlean, Laura A. Shackelton, Emily Andrews, Dale R. Webster, Stephen B. Lambert, Michael D. Nissen, Theo P. Sloots, Ian M Mackay	2008	107
7	Itaconate controls the severity of pulmonary fibrosis Science Immunology ·Patricia P. Ogger, Gesa J. Albers, Richard Hewitt, Brendan O’Sullivan, Joseph E. Powell, Emily Calamita, Poonam Ghai, Simone A. Walker, Peter McErlean, Peter Saunders, Shaun Kingston, Philip L. Molyneaux, John M. Halket, Robert Gray, Daniel C. Chambers, Toby M. Maher, Clare M. Lloyd, Adam J. Byrne	2020	104
8	The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis American Journal of Respiratory and Critical Care Medicine ·Sarah Allden, Patricia P. Ogger, Poonam Ghai, Peter McErlean, Richard Hewitt, Richard Toshner, Simone A. Walker, Peter Saunders, Shaun Kingston, Philip L. Molyneaux, Toby M. Maher, Clare M. Lloyd, Adam J. Byrne	2019	76
9	Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003 Journal of Clinical Virology ·Katherine E. Arden, Cassandra E. Faux, Nicholas T. O'Neill, Peter McErlean, Andreas Nitsche, Stephen B. Lambert, Michael D. Nissen, Theo P. Sloots, Ian M Mackay	2010	36
10	Human rhinovirus infection causes different DNA methylation changes in nasal epithelial cells from healthy and asthmatic subjects BMC Medical Genomics ·Peter McErlean, Sílvio Favoreto, Fabrício F. Costa, Junqing Shen, J. Quraishi, Assel Biyasheva, Jocelyn J. Cooper, Denise Scholtens, Elio F. Vanin, Maria F. Bonaldo, Hehuang Xie, Marcelo B. Soares, Pedro C. Avila	2014	35
11	Co-circulation of Four Human Coronaviruses (HCoVs) in Queensland Children with Acute Respiratory Tract Illnesses in 2004 Viruses ·Ian M Mackay, Katherine E. Arden, David J. Speicher, Nicholas T. O’Neil, Peter McErlean, Ristan M. Greer, Michael D. Nissen, Theo P. Sloots	2012	34
12	DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung Fibrosis American Journal of Respiratory and Critical Care Medicine ·Peter McErlean, Christopher G. Bell, Richard Hewitt, Zabreen Busharat, Patricia P. Ogger, Poonam Ghai, Gesa J. Albers, Emily Calamita, Shaun Kingston, Philip L. Molyneaux, Stephan Beck, Clare M. Lloyd, Toby M. Maher, Adam J. Byrne	2021	29
13	SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer American Journal of Respiratory and Critical Care Medicine ·Lucia Correia, Jo-Anne Johnson, Peter McErlean, Julien Bauer, Hassan Farah, Doris M. Rassl, Robert C. Rintoul, Tariq Sethi, Paul Lavender, Emma L. Rawlins, Trevor D. Littlewood, Gérard I. Evan, Frank McCaughan	2017	27
14	Profiling of H3K27Ac Reveals the Influence of Asthma on the Epigenome of the Airway Epithelium Frontiers in Genetics ·Peter McErlean, Audrey Kelly, Jaideep Dhariwal, Max Kirtland, Julie Watson, Ismael Ranz, Janet L. Smith, Alka Saxena, David J. Cousins, Antoon van Oosterhout, Roberto Solari, Michael R. Edwards, Sebastian L. Johnston, Paul Lavender	2020	15
15	IRF5 regulates airway macrophage metabolic responses Clinical & Experimental Immunology ·Gesa J. Albers, Jua Iwasaki, Peter McErlean, Patricia P. Ogger, P Ghai, Tariq Khoyratty, Irina A. Udalova, Clare M. Lloyd, Adam J. Byrne	2021	14
16	CRISPR-based reagents to study the influence of the epigenome on gene expression Clinical & Experimental Immunology ·Paul Lavender, Audrey Kelly, Eleanor Hendy, Peter McErlean	2018	7
17	Viral Diversity in Asthma Immunology and Allergy Clinics of North America ·Peter McErlean, Alyssa Greiman, Sílvio Favoreto, Pedro C. Avila	2010	6
18	DNA Methylation Profiling in Asthmatic and Non Asthmatic Nasal Epithelial Cells During Respiratory Virus Infection Journal of Allergy and Clinical Immunology ·Peter McErlean, Sílvio Favoreto, Fabrício F. Costa, Junquing Shen, Assel Biyasheva, Maria de Fátima Bonaldo, Denise Scholtens, Hehuang Xie, Marcelo B. Soares, Pedro C. Avila	2013	1

About Peter McErlean

Peter McErlean is a scholar working on Infectious Diseases, Emergency Medical Services, Epidemiology, Cardiology and Cardiovascular Medicine and Immunology, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Respiratory viral infections research (8 papers), Viral gastroenteritis research and epidemiology (6 papers), Epigenetics and DNA Methylation (5 papers), Viral Infections and Immunology Research (5 papers), IL-33, ST2, and ILC Pathways (3 papers), Asthma and respiratory diseases (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Neonatal Respiratory Health Research (2 papers). The work is most often cited by research in Infectious Diseases (593 citations), Epidemiology (939 citations), Emergency Medical Services (108 citations), Cardiology and Cardiovascular Medicine (287 citations) and Pulmonary and Respiratory Medicine (333 citations). Peter McErlean has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Ian M Mackay, Michael D. Nissen, Katherine E. Arden, Theo P. Sloots, Stephen B. Lambert, David J. Speicher, T. P. Sloots, Laura A. Shackelton, Cassandra E. Faux and Ristan M. Greer. Their work appears in journals such as Journal of Clinical Virology, American Journal of Respiratory and Critical Care Medicine, Clinical & Experimental Immunology, BMC Medical Genomics and Science Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact